Michels Family Financial LLC purchased a new position in The Procter & Gamble Company (NYSE:PG - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,144 shares of the company's stock, valued at approximately $359,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of PG. Cladis Investment Advisory LLC raised its position in Procter & Gamble by 5.2% during the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock valued at $806,000 after purchasing an additional 236 shares in the last quarter. FAS Wealth Partners Inc. increased its position in Procter & Gamble by 2.0% during the 4th quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock valued at $4,642,000 after buying an additional 549 shares in the last quarter. Berkshire Asset Management LLC PA grew its position in Procter & Gamble by 0.9% during the 4th quarter. Berkshire Asset Management LLC PA now owns 236,616 shares of the company's stock worth $38,833,000 after purchasing an additional 2,179 shares during the last quarter. Strategic Advisors LLC grew its holdings in shares of Procter & Gamble by 3.4% during the fourth quarter. Strategic Advisors LLC now owns 55,912 shares of the company's stock valued at $9,374,000 after buying an additional 1,818 shares during the last quarter. Finally, Richard C. Young & CO. LTD. increased its holdings in shares of Procter & Gamble by 2.1% in the fourth quarter. Richard C. Young & CO. LTD. now owns 123,853 shares of the company's stock valued at $20,764,000 after purchasing an additional 2,568 shares during the period. 65.77% of the stock is owned by institutional investors.
Insider Buying and Selling
In other news, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the sale, the chief executive officer now directly owns 51,965 shares in the company, valued at $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary A. Coombe sold 35,000 shares of Procter & Gamble stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $173.68, for a total value of $6,078,800.00. Following the sale, the chief executive officer now owns 22,051 shares of the company's stock, valued at approximately $3,829,817.68. This represents a 61.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 46,520 shares of company stock worth $7,909,388 in the last three months. Corporate insiders own 0.18% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on PG shares. Redburn Partners set a $161.00 target price on shares of Procter & Gamble in a report on Thursday, May 1st. Redburn Atlantic downgraded Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price target on the stock. in a research report on Thursday, May 1st. Piper Sandler lifted their price objective on Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research note on Monday, May 5th. Citigroup lowered their target price on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Finally, Bank of America reduced their price target on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Eight equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $178.52.
Check Out Our Latest Analysis on Procter & Gamble
Procter & Gamble Stock Performance
Procter & Gamble stock traded up $1.89 during trading hours on Tuesday, reaching $167.75. 11,416,704 shares of the stock were exchanged, compared to its average volume of 7,291,845. The Procter & Gamble Company has a 52-week low of $156.58 and a 52-week high of $180.43. The stock has a market cap of $393.30 billion, a P/E ratio of 26.71, a P/E/G ratio of 3.76 and a beta of 0.41. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The firm's 50 day moving average is $164.13 and its 200 day moving average is $167.34.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The firm had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. During the same period in the previous year, the business earned $1.52 earnings per share. The company's revenue for the quarter was down 2.1% compared to the same quarter last year. Analysts predict that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Monday, April 21st were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Monday, April 21st. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 annualized dividend and a yield of 2.52%. Procter & Gamble's payout ratio is currently 66.98%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report